Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Tissue Transplantation01:24

Tissue Transplantation

366
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
366
Cell-mediated Immune Responses01:40

Cell-mediated Immune Responses

68.3K
Overview
68.3K
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

243
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
243
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

330
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
330

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Outcomes Following Antifungal Treatment for <i>Candida</i> Growth in Bile Cultures Collected During Endoscopic Retrograde Cholangiopancreatography.

Journal of fungi (Basel, Switzerland)·2026
Same author

Performance of Diagnostic Tests for Histoplasmosis Across Clinical Syndromes and Immune Statuses.

Open forum infectious diseases·2025
Same author

An outbreak of acute pulmonary histoplasmosis after exposure to guano in a hollow tree in Ecuador.

Travel medicine and infectious disease·2025
Same author

Interferon-γ Therapy in Patients With Refractory Disseminated Coccidioidomycosis.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2025
Same author

Regulatory T Cells Kinetics in Immune Reconstitution Inflammatory Syndrome in HIV-Tuberculosis Co-Infected Individuals.

Journal of molecular and clinical medicine·2025
Same author

Diagnosis of Coccidioidomycosis with the Second-Generation Miravista IgG and IgM Enzyme Immunoassay and the Role of Adding Miravista Coccidioides Antigen Detection to Immunodiagnostic Assays.

Medical mycology·2024

Related Experiment Video

Updated: Jul 2, 2025

Trans-vivo Delayed Type Hypersensitivity Assay for Antigen Specific Regulation
11:49

Trans-vivo Delayed Type Hypersensitivity Assay for Antigen Specific Regulation

Published on: May 2, 2013

16.1K

Histoplasmosis in Solid Organ Transplantation.

Nicolas Barros1,2,3, L Joseph Wheat3

  • 1Department of Medicine, Indiana University School of Medicine, Indianapolis, IN 46202, USA.

Journal of Fungi (Basel, Switzerland)
|February 23, 2024
PubMed
Summary

Histoplasmosis, caused by Histoplasma capsulatum, poses a significant risk to solid organ transplant recipients, often leading to severe disease. Prompt diagnosis and tailored therapy are crucial for managing this fungal infection in this vulnerable population.

Keywords:
Histoplasmahistoplasmosissolid organ transplanttransplant

More Related Videos

Orthotopic Hind Limb Transplantation in the Mouse
07:15

Orthotopic Hind Limb Transplantation in the Mouse

Published on: February 12, 2016

11.7K
Passive Administration of Monoclonal Antibodies Against H. capsulatum and Others Fungal Pathogens
09:57

Passive Administration of Monoclonal Antibodies Against H. capsulatum and Others Fungal Pathogens

Published on: February 14, 2011

12.0K

Related Experiment Videos

Last Updated: Jul 2, 2025

Trans-vivo Delayed Type Hypersensitivity Assay for Antigen Specific Regulation
11:49

Trans-vivo Delayed Type Hypersensitivity Assay for Antigen Specific Regulation

Published on: May 2, 2013

16.1K
Orthotopic Hind Limb Transplantation in the Mouse
07:15

Orthotopic Hind Limb Transplantation in the Mouse

Published on: February 12, 2016

11.7K
Passive Administration of Monoclonal Antibodies Against H. capsulatum and Others Fungal Pathogens
09:57

Passive Administration of Monoclonal Antibodies Against H. capsulatum and Others Fungal Pathogens

Published on: February 14, 2011

12.0K

Area of Science:

  • Medical Mycology
  • Infectious Diseases
  • Transplant Medicine

Background:

  • Histoplasma capsulatum is a dimorphic fungus causing histoplasmosis.
  • While typically self-resolving in immunocompetent individuals, it presents a higher risk for solid organ transplant (SOT) recipients.
  • SOT recipients face increased risk of symptomatic disease and dissemination.

Purpose of the Study:

  • To review the pathogenesis, epidemiology, clinical manifestations, and management of histoplasmosis.
  • To highlight the specific challenges and considerations for SOT recipients.
  • To provide a comprehensive overview for clinicians managing this population.

Main Methods:

  • Literature review focusing on Histoplasma capsulatum in SOT recipients.
  • Synthesis of information on diagnosis, treatment, and outcomes.
  • Analysis of epidemiological trends and risk factors.

Main Results:

  • Histoplasmosis diagnosis in SOT recipients relies on direct pathogen observation or detection of antigens, antibodies, or nucleic acids.
  • All SOT recipients with histoplasmosis require treatment.
  • Treatment choice and duration are guided by disease severity.

Conclusions:

  • Histoplasmosis is a serious concern in SOT recipients, with potential for extrapulmonary dissemination.
  • Early diagnosis and appropriate antifungal therapy are essential for favorable outcomes.
  • Management strategies must be individualized based on clinical presentation and disease severity.